Literature DB >> 9043870

Prevalence and parental origin of de novo RET mutations in Hirschsprung's disease.

L Yin1, M Seri, V Barone, T Tocco, M Scaranari, G Romeo.   

Abstract

In contrast with the reported almost exclusive paternal origin of de novo mutations in MEN 2A, FMTC and MEN 2B, de novo mutations in Hirschsprung patients arise both on paternal and maternal chromosomes. This distinctive feature of RET mutations associated with Hirschsprung's disease and of the RET mutations associated with thyroid cancer indicates a basic biological difference between the mutational events leading to the different phenotypes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9043870     DOI: 10.1159/000472232

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  5 in total

Review 1.  [Molecular biology, basic research and diagnosis of Hirschsprung's disease].

Authors:  G Martucciello; O Luinetti; P Romano; U Magrini
Journal:  Pathologe       Date:  2007-03       Impact factor: 1.011

Review 2.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

3.  Evidence that replication-associated mutation alone does not explain between-chromosome differences in substitution rates.

Authors:  Catherine J Pink; Siva K Swaminathan; Ian Dunham; Jane Rogers; Andrew Ward; Laurence D Hurst
Journal:  Genome Biol Evol       Date:  2009-04-30       Impact factor: 3.416

4.  Novel MLPA procedure using self-designed probes allows comprehensive analysis for CNVs of the genes involved in Hirschsprung disease.

Authors:  Avencia Sánchez-Mejías; Rocio Núñez-Torres; Raquel M Fernández; Guillermo Antiñolo; Salud Borrego
Journal:  BMC Med Genet       Date:  2010-05-11       Impact factor: 2.103

5.  A novel study of copy number variations in Hirschsprung disease using the multiple ligation-dependent probe amplification (MLPA) technique.

Authors:  Rocío Núñez-Torres; Raquel M Fernández; Manuel López-Alonso; Guillermo Antiñolo; Salud Borrego
Journal:  BMC Med Genet       Date:  2009-11-19       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.